NEMEC SARAH (Senior VP, Finance and PAO) made both purchases and sales at BOLT BIOTHERAPEUTICS, INC.
Purchased 36.0% of their position (509.00 shares) and sold 31.5% of their position (7.84K shares) — review individual transaction dates and prices for directional context.
P · 1S · 3
Filed: 9/21/2026ACC: 0001193125-26-396892
Officer· Senior VP, Finance and PAO
Since Jan 2026
-7.33K
Net shares
Net seller
$26.1K
Total sold
4
Open market trades
1B · 3S
4
Total transactions
509.00 acquired · 7.84K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+509.00
Price / share
$3.88
Trade value
$1.97K
% of position
36.0%
6/5/2026
1.42K→1.92K
Common Stock
Direct
Shares
−843.00
Price / share
$3.77
Trade value
$3.18K
% of position
3.4%
9/16/2026
24.92K→24.08K
Common Stock
Direct
Shares
−2.92K
Price / share
$3.32
Trade value
$9.70K
% of position
12.1%
9/17/2026
24.08K→21.16K
Common Stock
Direct
Shares
−4.08K
Price / share
$3.24
Trade value
$13.19K
% of position
19.3%
9/18/2026
21.16K→17.08K
Total
Net shares
−7.33K
Net value
-$24.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | P · Purchase | +509.00 | $3.88 | $1.97K | 36.0% | 1.42K | 1.92K |
| Common Stock Direct | 9/16/2026 | S · Sale | −843.00 | $3.77 | $3.18K | 3.4% | 24.92K | 24.08K |
| Common Stock Direct | 9/17/2026 | S · Sale | −2.92K | $3.32 | $9.70K | 12.1% | 24.08K | 21.16K |
| Common Stock Direct | 9/18/2026 | S · Sale | −4.08K | $3.24 | $13.19K | 19.3% | 21.16K | 17.08K |
| Total | −7.33K | -$24.10K | ||||||
Derivative Transactions0
No derivative transactions reported